StemCells Inc. (Nasdaq: STEM) terminated a mid-stage clinical trial and will wind down the company. The stock price plummeted $2.46 to close at $0.57.
StemCells will shut down
May 31, 2016 at 16:48 PM EDT
|
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Home | News | Travel | Restaurants | Nightlife | Things To Do | Shopping | Calendar | Directory | Real Estate | Blog | More
|